Page last updated: 2024-12-08
brevicomin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
brevicomin: RN given refers to (1R-exo)-isomer; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 181255 |
| SCHEMBL ID | 435182 |
| MeSH ID | M0059117 |
Synonyms (29)
| Synonym |
|---|
| 20290-99-7 |
| exo-brevicomin |
| nsc-154758 |
| brevicomin |
| (1r,5s,7r)-7-ethyl-5-methyl-6,8-dioxabicyclo[3.2.1]octane |
| (?)-exobrevicomin |
| 6,8-dioxabicyclo(3.2.1)octane, 7-ethyl-5-methyl-, exo- |
| (?)-exo-brevicomin |
| 60018-04-4 |
| AKOS006274917 |
| 6,8-dioxabicyclo(3.2.1)octane, 7-ethyl-5-methyl-, (1r-exo)- |
| nsc 154758 |
| kpu1sw45cd , |
| 6,8-dioxabicyclo(3.2.1)octane, 7-ethyl-5-methyl-, (1r,5s,7r)- |
| unii-kpu1sw45cd |
| 7-ethyl-5-methyl-6,8-dioxabicyclo(3.2.1)octane |
| SCHEMBL435182 |
| (+)-exo-brevicomin |
| (1s,5r,6r)-1-methyl-6-ethyl-7,8-dioxabicyclo(3.2.1)octane |
| 6,8-dioxabicyclo(3.2.1)octane, 7-ethyl-5-methyl- |
| (1r,5s,7r)-7-ethyl-5-methyl-6,8-dioxabicyclo(3.2.1)octane |
| 6-ethyl-1-methyl-7,8-dioxabicyclo(3.2.1)octane |
| (1.alpha.)-5.beta.-methyl-7.alpha.-ethyl-6,8-dioxabicyclo(3.2.1)octane |
| (1r)-exo-7-ethyl-5-methyl-6,8-dioxabicyclo(3.2.1)octane |
| exo-7-ethyl-5-methyl-6,8-dioxabicyclo(3.2.1)octane |
| j16.634k , |
| exo-brevocomin |
| DTXSID2041678 |
| Q27282380 |
Research Excerpts
Overview
Endo-Brevicomin is a pheromone component of the tree-killing bark beetle Dendroctonus frontalis Zimmermann. It has a biphasic dose-response curve, enhancing attraction at low release rates but reducing attraction at high rates.
| Excerpt | Reference | Relevance |
|---|---|---|
| "endo-Brevicomin is a pheromone component of the tree-killing bark beetle Dendroctonus frontalis Zimmermann (Coleoptera: Curculionidae: Scolytinae) that has a biphasic dose-response curve, enhancing attraction at low release rates but reducing attraction at high rates." | ( Some Effects of endo-Brevicomin Background on Southern Pine Beetle (Coleoptera: Curculionidae: Scolytinae) Aggregation Behavior. Brownie, C; Sullivan, BT, 2021) | 1.4 |
Dosage Studied
| Excerpt | Relevance | Reference |
|---|---|---|
| " endo-Brevicomin is a pheromone component of the tree-killing bark beetle Dendroctonus frontalis Zimmermann (Coleoptera: Curculionidae: Scolytinae) that has a biphasic dose-response curve, enhancing attraction at low release rates but reducing attraction at high rates." | ( Some Effects of endo-Brevicomin Background on Southern Pine Beetle (Coleoptera: Curculionidae: Scolytinae) Aggregation Behavior. Brownie, C; Sullivan, BT, 2021) | 1.42 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (35)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 5 (14.29) | 18.7374 |
| 1990's | 4 (11.43) | 18.2507 |
| 2000's | 12 (34.29) | 29.6817 |
| 2010's | 12 (34.29) | 24.3611 |
| 2020's | 2 (5.71) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 27.91
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (27.91) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 36 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||